These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16457761)

  • 1. [Epidermal necrolysis: mechanisms of keratinocyte apoptosis].
    Roujeau JC; Gélard K; Bensussan A
    Med Sci (Paris); 2006 Feb; 22(2):188-91. PubMed ID: 16457761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
    Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
    J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.
    Nassif A; Bensussan A; Dorothée G; Mami-Chouaib F; Bachot N; Bagot M; Boumsell L; Roujeau JC
    J Invest Dermatol; 2002 Apr; 118(4):728-33. PubMed ID: 11918724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Toxic Epidermal Necrolysis.
    Harris V; Jackson C; Cooper A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
    Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
    Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.
    Nassif A; Bensussan A; Boumsell L; Deniaud A; Moslehi H; Wolkenstein P; Bagot M; Roujeau JC
    J Allergy Clin Immunol; 2004 Nov; 114(5):1209-15. PubMed ID: 15536433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Khalili B; Bahna SL
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI
    Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic cell death in toxic epidermal necrolysis: the Fas ligand assumption.
    Gravante G; Esposito G; Filingeri V; Delogu D; Castrì F; Montone A
    Arch Dermatol Res; 2006 Mar; 297(9):430-1; author reply 432. PubMed ID: 16429298
    [No Abstract]   [Full Text] [Related]  

  • 10. Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.
    de Araujo E; Dessirier V; Laprée G; Valeyrie-Allanore L; Ortonne N; Stathopoulos EN; Bagot M; Bensussan A; Mockenhaupt M; Roujeau JC; Tsapis A
    Exp Dermatol; 2011 Feb; 20(2):107-12. PubMed ID: 21255088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Saeed HN; Chodosh J
    Semin Ophthalmol; 2016; 31(1-2):85-90. PubMed ID: 26959133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
    Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidermic necrolysis: advances in pathogenesis].
    Roujeau JC
    Ann Dermatol Venereol; 2000 May; 127(5):546-7. PubMed ID: 10863193
    [No Abstract]   [Full Text] [Related]  

  • 14. A Review of the Pathogenesis of Toxic Epidermal Necrolysis.
    Kinoshita Y; Saeki H
    J Nippon Med Sch; 2016; 83(6):216-222. PubMed ID: 28133001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
    Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis.
    Viard-Leveugle I; Gaide O; Jankovic D; Feldmeyer L; Kerl K; Pickard C; Roques S; Friedmann PS; Contassot E; French LE
    J Invest Dermatol; 2013 Feb; 133(2):489-98. PubMed ID: 22992806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Noe MH; Micheletti RG
    Clin Dermatol; 2020; 38(6):607-612. PubMed ID: 33341195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
    Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.
    Viard I; Wehrli P; Bullani R; Schneider P; Holler N; Salomon D; Hunziker T; Saurat JH; Tschopp J; French LE
    Science; 1998 Oct; 282(5388):490-3. PubMed ID: 9774279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.